Login
← Go Back
Astrazeneca Pharma India
ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in
Stock Price vs Company Growth
1d
3.7%
1w
0.5%
1m
0.9%
3m
2.2%
6m
4.4%
1y
9.8%
5y
18.2%
10y
23.5%
all
15.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 8,655 3.7%
7,630
9,151
Company Overview
Sales
2,276 Cr
Growth: 30.6%
Profit after Tax
186 Cr
Growth: -6.7%
Mid Cap
21,638 Cr
P/E: 115.4x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 2,276
Growth 30.6%
EBITDA 11.5%
P/S 9.5x
Dividend 0.3%
P/E 115.4x
Book Value ₹ 349
PEG Ratio 3.8x
ROE 21.3%
P/B 24.8x
Shareholding Pattern
Institutions
Promoters
Astrazeneca Pharmaceuticals Ab
75.0 %
Others
Tejas Bhalchandra Trivedi
2.67 %
Shivani T. Trivedi
1.98 %
Minaxi Bhalchandra Trivedi
1.84 %
Iepf
0.46 %
Increase    Decrease    No change
Company Profile Detailed
AstraZeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. The company engages in execution of clinical studies to generate high quality data eligible for submissions to regulatory agencies across the world aimed at developing life altering medical products.
Belongs to (23 Indices) view more
Investors (43)
astra.ph...
all.body...
mansfiel...
Followers (3)
nitin2
keerthi
deepak